for safety and clinical fit
At the 2.5 mg starting dose, a 30 mg vial provides 12 weeks of doses
Safety, Eligibility, and When Cost-Focused Decisions Require Medical Oversight Choosing based on cost alone risks overlooking critical contraindications: history of medullary thyroid cancer, pancreatitis, severe kidney disease, or pregnancy require medical evaluation before any GLP-1 initiation
Full story here (exclusive on Business Today): #Pharma #Healthcare #Diabetes #NovoNordisk #BusinessOfHealth To view or add a comment, sign in Praxis Precision Medicines Announces Positive Topline Results from Two Pivotal Phase 3 Studies of Ulixacaltamide HCl in the Essential3 Program for Essential Tremor
Yet, contrary to these findings, metformin does not directly inhibit DPP-4 activity in vitro [9, 14, 16]
Nutritional counseling should be sought to ensure diet adequacy